Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria

Uzochukwu, Benjamin S. C.; Chiegboka, Lausdeus O.; Enwereuzo, Chibuike; Usonwanne Nwosu; Okorafor, David; Onwujekwe, Obinna E.; Uguru, Nkoli P.; Sibeudu, Florence T.; Ezeoke, Ogochukwu P.
January 2010
BMC Public Health;2010, Vol. 10, p486
Academic Journal
Background: Rapid diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) have been widely advocated by government and the international community as cost-effective tools for diagnosis and treatment of malaria. ACTs are now the first line treatment drug for malaria in Nigeria and RDTs have been introduced by the government to bridge the existing gaps in proper diagnosis. However, it is not known how readily available these RDTs and ACTs are in public and private health facilities and whether health workers are actually using them. Hence, this study investigated the levels of availability and use of RDTs and ACTs in these facilities. Methods: The study was undertaken in Enugu state, southeast Nigeria in March 2009. Data was collected from heads of 74 public and private health facilities on the availability and use of RDTs and ACTs. Also, the availability of RDTs and the types of ACTs that were available in the facilities were documented. Results: Only 31.1% of the health facilities used RDTs to diagnose malaria. The majority used the syndromic approach. However, 61.1% of healthcare providers were aware of RDTs. RDTs were available in 53.3% of the facilities. Public health facilities and health facilities in the urban areas were using RDTs more and these were mainly bought from pharmacy shops and supplied by NGOs. The main reasons given for non use are unreliability of RDTs, supply issues, costs, preference for other methods of diagnosis and providers' ignorance. ACTs were the drug of choice for most public health facilities and the drugs were readily available in these facilities. Conclusion: Although many providers were knowledgeable about RDTs, not many facilities used it. ACTS were readily available and used in public but not private health facilities. However, the reported use of ACTs with limited proper diagnosis implies that there could be high incidence of inappropriate case management of malaria which can also increase the economic burden of illnesses. Government and donors should ensure constant availability of RDTs in both public and private facilities, so that every treatment with ACTs is accompanied with proper diagnosis.


Related Articles

  • Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Alba, Sandra; Hetzel, Manuel W.; Goodman, Catherine; Dillip, Angel; Liana, Jafari; Mshinda, Hassan; Lengeler, Christian // Malaria Journal;2010, Vol. 9, p164 

    Background: To improve access to treatment in the private retail sector a new class of outlets known as accredited drug dispensing outlets (ADDO) was created in Tanzania. Tanzania changed its first-line treatment for malaria from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (ALu)...

  • Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective. Alba, Sandra; Dillip, Angel; Hetzel, Manuel W.; Mayumana, Iddy; Mshana, Christopher; Makemba, Ahmed; Alexander, Mathew; Obrist, Brigit; Schulze, Alexander; Kessy, Flora; Mshinda, Hassan; Lengeler, Christian // Malaria Journal;2010, Vol. 9, p163 

    Background: The ACCESS programme aims at understanding and improving access to prompt and effective malaria treatment. Between 2004 and 2008 the programme implemented a social marketing campaign for improved treatment-seeking. To improve access to treatment in the private retail sector a new...

  • Can Markets Cure Malaria? Rauch, Jonathan // National Journal;10/11/2008, p9 

    The article discusses the challenges faced by Affordable Medicines Facility Malaria, a malaria treatment program in the developing world. Resistance to Artemisinin drug can be slowed if used in combination with other drugs but is more expensive making treatment an economic problem. Economist...

  • Prescription practices and availability of artemisinin monotherapy in India: where do we stand?  // Malaria Journal;2011, Vol. 10 Issue 1, p360 

    The article presents a study that evaluated the treatment practices for malaria and artemisinin monotherapy prescription in India. For this 511 physicians, 530 pharmacists and 1,832 patients were interviewed and logistic regression was used to determine factors associated with arteminsinin...

  • Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania. Khatib, Rashid A.; Selemani, Majige; Mrisho, Gumi A.; Masanja, Irene M.; Amuri, Mbaraka; Njozi, Mustafa H.; Kajungu, Dan; Kuepfer, Irene; Abdulla, Salim M.; Savigny, Don de // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background: Artemisinin-based combination treatment (ACT) has been widely adopted as one of the main malaria control strategies. However, its promise to save thousands of lives in sub-Saharan Africa depends on how effective the use of ACT is within the routine health system. The INESS platform...

  • Advances in the treatment of malaria. Bell, D. J. // British Journal of Hospital Medicine (17508460);May2010, Vol. 71 Issue 5, p246 

    The article discusses the development in the treatment of malaria in Great Britain. It primarily explores several types of malaria vaccine that could be effective for a specific type of malaria species. Moreover, it examines the development of these vaccines, focusing on the World Health...

  • Public health system readiness to treat malaria in Odisha State of India. Hussain, Mohammad A.; Dandona, Lalit; Schellenberg, David // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background: Early diagnosis and prompt treatment is a cornerstone of malaria control. In India, artemisinin combination therapy (ACT) became the first-line treatment for falciparum malaria and rapid diagnostic test (RDTs) kits were recommended for use at the grass-root level in the new malaria...

  • Efficacy and Safety of Artemether in the Treatment of Chronic Fascioliasis in Egypt: Exploratory Phase-2 Trials. Keiser, Jennifer; Sayed, Hanan; El-Ghanam, Maged; Sabry, Hoda; Anani, Saad; El-Wakeel, Aly; Hatz, Christoph; Utzinger, Jürg; El-Din, Sayed Seif; El-Maadawy, Walaa; Botros, Sanaa // PLoS Neglected Tropical Diseases;Sep2011, Vol. 5 Issue 9, p1 

    Background: Fascioliasis is an emerging zoonotic disease of considerable veterinary and public health importance. Triclabendazole is the only available drug for treatment. Laboratory studies have documented promising fasciocidal properties of the artemisinins (e.g., artemether). Methodology: We...

  • The magnitude and trend of artemetherlumefantrine stock-outs at public health facilities in Kenya.  // Malaria Journal;2012, Vol. 11 Issue 1, p37 

    The article presents findings of a research conducted on examining the magnitude and trend of artemether-lumefantrine (AL) stock-outs at public health facilities in Kenya. Under the research, data collected between January 2010 and June 2011 as part of 18 monthly cross-sectional surveys were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics